Drugs / SEL-068
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01478893 | Nov 2011 → Jan 2013 | — | Selecta Biosciences, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SEL-068 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01478893 ↗ |
| Modality | Vaccine | “SEL-068 Vaccine” NCT01478893 ↗ |
| Route | Subcutaneous | “Increasing subcutaneous doses of SEL-068 will be administered” NCT01478893 ↗ |